/PANC

PANC Stock - Panacos Pharmaceuticals, Inc.

Q: What is the analyst price target for PANC?

Analyst price target information is not currently available for PANC.

Q: What is PANC's market cap?

Market capitalization information is not currently available for PANC.

Healthcare|Biotechnology|OTC

$0.00+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for PANC

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2003

FY2004

FY2005

FY2006

FY2007

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta-58.99

52W High$0.00

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2007	FY2006	FY2005	FY2004	FY2003
Revenue	$180,000	$284,000	$1.05M	$1.34M	$1.08M
Gross Profit	$180,000	$284,000	$1.05M	$1.34M	$1.08M
Gross Margin	100.0%	100.0%	100.0%	100.0%	100.0%
Operating Income	$39.02M	$41.70M	$59.98M	$11.97M	$4.33M
Net Income	$-37,459,000	$-38,110,000	$-59,078,000	$-12,038,000	$-4,508,000
Net Margin	-20810.6%	-13419.0%	-5631.8%	-900.4%	-418.2%
EPS	$-0.70	$-0.75	$-1.72	$-14.51	$-2.74

Company Overview

Panacos Pharmaceuticals, Inc., a development stage biotechnology company, engages in the discovery and development of small-molecule oral drugs designed to treat human immunodeficiency virus (HIV) and other human viral diseases. The company's discovery technologies focus on novel targets in the virus life cycle, including virus maturation and virus fusion. Its product pipeline includes second- and third-generation programs in HIV maturation inhibition. The company was founded in 1999 and is headquartered in Watertown, Massachusetts.

Frequently Asked Questions about PANC

What is PANC's current stock price?

Panacos Pharmaceuticals, Inc. (PANC) is currently trading at $0.00 per share. The stock has moved +0.00% today.

What is the analyst price target for PANC?

No analyst price targets are currently available for this stock.

What sector is Panacos Pharmaceuticals, Inc. in?

Panacos Pharmaceuticals, Inc. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the OTC exchange.

What is PANC's market cap?

Panacos Pharmaceuticals, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.

Does PANC pay dividends?

No, Panacos Pharmaceuticals, Inc. does not currently pay a dividend to shareholders.